BIGBEAR
PHARMACEUTICAL
Selpercatinib is a highly selective and potent kinase inhibitor that exerts its therapeutic effect by selectively targeting and inhibiting mutated or fusion forms of the RET gene.
AuthenticGuaranteeFast DeliveryPrivacy During Selpercatinib treatment, please complete regular re-examinations of liver function, blood pressure, electrocardiograms (ECGs), electrolytes, an···【More】
Update: 23 Sep,2026Source: BigbearViews: 164
Selpercatinib is a highly selective RET kinase inhibitor that blocks tumor growth signaling by inhibiting abnormally activated RET proteins. Treatment···【More】
Update: 21 Sep,2026Source: BigbearViews: 154
During treatment with Selpercatinib, patients should avoid or stagger the administration of acid-reducing agents (stomach medications) and St. John···【More】
Update: 21 Sep,2026Source: BigbearViews: 153
Selpercatinib is a treatment option recommended by the National Comprehensive Cancer Network (NCCN) for certain patients with RET-positive metastatic ···【More】
Update: 12 Feb,2026Source: BigbearViews: 216
If you experience side effects, your doctor may change your dose, temporarily stop, or permanently discontinue treatment with selpercatinib. Do not ch···【More】
Update: 12 Feb,2026Source: BigbearViews: 224
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
